Exelixis | EXEL - Рыночная капитализация





Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Akebia Therapeutics USD 427M 297M 2025-12
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 36.36B 9.13B 2025-12
BioMarin Pharmaceutical USD 10.57B 290M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cytokinetics USD 9.25B 1.48B 2026-05
Eisai JPY 1.31T 140.95B 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Esperion Therapeutics USD 885M 351M 2025-12
Exelixis USD 12.9B 1.15B 2026-05
Genmab DKK 20.48B 1.02B 2025-12
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
MacroGenics USD 102M 4M 2025-12
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Neurocrine Biosciences USD 13.34B 800M 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 148.08B 6.51B 2026-05
Takeda JPY 7.64T 774.9B 2025-12
Ultragenyx Pharmaceutical USD 2.04B 176M 2026-05
Xencor USD 1.09B 256M 2025-12